Apply

Investing in a Healthy Future

The VIC Investor Network (VIN) features high-impact, high-upside life science companies, with experienced done-it-before management teams, co-investment with experienced investors, and more.

Browse Companies
Register for a VIC Investor Network Webinar

Angel investing with confidence

VIN addresses the primary challenges of angel investing in science and technology-driven innovation

Issues of Angel Investing
Register for a VIC Investor Network Webinar

Protection

Co-investment on same terms with larger investors and built-in investment safeguards

Investor Protections
Register for a VIC Investor Network Webinar

Diversification

Investments may be made as low as $5k per invested company allowing more investments and portfolio diversification

Diversification
Register for a VIC Investor Network Webinar

Liquidity

Secondary market for VIN shares gives members opportunity for liquidity prior to portfolio exits

Liquidity
Register for a VIC Investor Network Webinar
previous arrowprevious arrow
next arrownext arrow
Slider
INNOVATION

VIC’s Innovation Ecosystem

Turnkey support through all stages of portfolio companies’ development.

Learn More

Incubate high-potential ideas for future VIC portfolio companies.

Learn More

Equity funding for proof-of-concept through commercial product roll-out.

Learn More

Series A/B funding to reach major value-enhancing milestones

Learn More
LATEST NEWS
More News
PORTFOLIO

Our Portfolio Companies

Companies built from the ground up based on high impact technologies exclusively licensed from top research institutions around the world. View All Companies 

Now Funding
Solenic Medical, Inc. is a medical device company developing an innovative non-invasive treatment for infected metallic implants in the body, reducing the need for additional surgeries.
https://solenic.com
View Details
Funded
Akeso Biomedical is an animal performance and food safety company developing new solutions to improve gut health and treat bacterial infections using a broad-spectrum chemistry.
https://akesobiomedical.com
View Details
Funded
ACQUIRED | Ascendant Dx is a bioscience company whose mission is to commercialize disruptive diagnostic technologies aiding identification and treatment for diseases of women and children.
View Details
Funded
BiologicsMD is developing highly targeted, novel human therapeutics for hair loss diseases and conditions, as well as severe bone disorders.
http://biologicsmd.com
View Details
Funded
ACQUIRED | BlueInGreen (BIG) designs, manufactures and services the most efficient gas dissolution equipment for water and wastewater treatment.
https://blueingreen.com
View Details
Funded
Calyxo is developing a disruptive solution for kidney stone removal that is faster, easier, and better for patients, clinicians and hospitals.
View Details
View All Companies